文献速递细菌感染、耐药与抗菌药物

产超广谱β-内酰胺酶阳性ST131大肠埃希菌对碳青霉烯暴露初始适应的综合评估

Comprehensive Assessment of Initial Adaptation of Extended-Spectrum β-Lactamase-Positive ST131 Escherichia coli to Carbapenem Exposure.
PubMed 文献 · J Infect Dis · 2025-01-01

研究测量了来自184例ST131菌血症队列的13株产ESBL ST131临床分离株对厄他培南的突变频率,发现初始ESBL基因拷贝数与突变频率正相关(r=0.87,P<1e-5)。全基因组测序显示初始应答为ESBL基因拷贝数增加或Omp基因突变;在菌株MB1860中,两种实验演化平台均通过IS26介导的伪复合转座子增加blaCTX-M-15拷贝数,Omp基因稳定突变仅在长期递增碳青霉烯暴露后检出。

要点

  • 13株产ESBL ST131均检出厄他培南突变频率,初始ESBL基因拷贝数与突变频率正相关(r=0.87,P<1e-5)。
  • 初始厄他培南暴露导致ESBL基因拷贝数显著增加或Omp基因突变,亚克隆特异性相关。
  • MB1860在两种实验演化平台中均通过IS26介导的伪复合转座子增加blaCTX-M-15拷贝数。

核心结论

  • ESBL基因扩增是对初始碳青霉烯暴露的保守应答,尤其在高危ST131 C2/H30Rx亚克隆中;靶向这种扩增可能有助于减缓碳青霉烯耐药的发展。

研究设计与样本

  • 使用波动实验测量来自多样化(n=184)ST131菌血症队列的13株产ESBL ST131临床分离株的碳青霉烯突变频率,并进行全基因组测序表征。
  • 对ST131 C2/H30Rx分离株MB1860在长期递增碳青霉烯暴露下,使用2种实验演化平台进行基因组、转录组和孔蛋白分析,以测量快速与缓慢适应。

主要发现

  • 所有13株产ESBL ST131菌株均检出厄他培南突变频率,初始ESBL基因拷贝数与突变频率正相关(r=0.87,P<1e-5)。
  • 突变体的全基因组测序显示,对厄他培南暴露的初始应答导致ESBL基因拷贝数显著增加或Omp基因突变,且无ESBL基因扩增,具有亚克隆特异性关联。
  • 在两种实验演化平台中,MB1860通过模块化、IS26介导的伪复合转座子增加blaCTX-M-15拷贝数来应答初始厄他培南暴露。
  • 伪复合转座子内基因的转录水平增加是两种实验演化平台中保守的表达信号。
  • Omp编码基因的稳定突变仅在长期递增碳青霉烯暴露后检出,与临床观察一致。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It remains unclear how high-risk Escherichia coli lineages, like sequence type (ST) 131, initially adapt to carbapenem exposure in their progression to carbapenem resistance. METHODS: Carbapenem mutation frequency was measured in multiple subclades of extended-spectrum β-lactamase (ESBL)-positive ST131 clinical isolates using a fluctuation assay followed by whole genome sequencing (WGS) characterization. Genomic, transcriptomic, and porin analyses of the ST131 C2/H30Rx isolate MB1860, under prolonged, increasing carbapenem exposure was performed using 2 experimental evolutionary platforms to measure fast versus slow adaptation. RESULTS: All 13 ESBL-positive ST131 strains selected from a diverse (n = 184) ST131 bacteremia cohort had detectable ertapenem (ETP) mutational frequencies, with a positive correlation between initial ESBL gene copy number and mutation frequency (r = 0.87, P < 1e-5). WGS analysis of mutants showed that initial response to ETP exposure resulted in significant increases in ESBL gene copy numbers or mutations in Omp genes in the absence of ESBL gene amplification with subclade-specific associations. In both experimental evolutionary platforms, MB1860 responded to initial ETP exposure by increasing blaCTX-M-15 copy numbers via modular, IS26-mediated pseudocompound transposons (PCTns). Increased transcript level of genes present within the PCTn was a conserved expression signal in both experimental evolutionary platforms. Stable mutations in Omp encoding genes were detected only after prolonged increasing carbapenem exposure, consistent with clinical observations. CONCLUSIONS: ESBL gene amplification is a conserved response to initial carbapenem exposure, especially within the high-risk ST131 C2/H30Rx subclade. Targeting such amplification could assist with mitigating carbapenem resistance development.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Shropshire WC, Song X, Bremer J, et al. Comprehensive Assessment of Initial Adaptation of Extended-Spectrum β-Lactamase-Positive ST131 Escherichia coli to Carbapenem Exposure. J Infect Dis. 2025. PMID: 39602497. doi:10.1093/infdis/jiae587

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。